Role of intravesical BCG for the treatment of superficial bladder cancer

ABSTRACT

A controlled trial was performed on 30 patients to evaluate the efficacy of intravesical Pasteur strain bacillus Calmetle-Guerin [BCG] administration as a prophylaxis against tumor recurrence after complete endoscopic resection of superficial bladder cancer. The treatment schedule consisting of 6 weeks course of BCG instillation 10 days after transurethral resection of bladder tumor [TURT]. Patients who were treated with BCG were significantly better as regards to tumor recurrence, the tumor free interval, stage and grade of the recurrent tumors is significantly better than the control group